David Fronk

David Fronk is an experienced executive in the healthcare sector, currently serving as Chief Revenue Officer at Interpath Laboratory, Inc. since September 2022. Previously, David held key roles including Senior Vice President of Business Development and Sales at Anelto, where David developed strategies for the healthcare division focused on remote patient monitoring. As Chief Operating Officer at Total Care 2U, David contributed to a model that significantly reduced hospitalizations and ER visits by delivering comprehensive care at home. David's extensive background also includes leadership positions at Home Team, US Health Group, Cantex, Staff Care, Aventis Pharmaceuticals, and Bayer Pharmaceuticals, where David consistently drove sales growth, built strong sales teams, and implemented successful business strategies. David holds a degree in Biology and Chemistry from Texas A&M University.